Related Experiment Videos
Bronchopulmonary dysplasia: a review for the pediatrician
J M Fiascone1, T T Rhodes, S R Grandgeorge
1Maternal and Child Health, Dartmouth Medical School, Hanover, New Hampshire.
Insights
Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants and children, often linked to preterm birth and respiratory distress syndrome. Mechanical ventilation and oxygen toxicity are suspected causes, highlighting the need for more research.
Area of Science:
- Pulmonary Medicine
- Neonatology
- Pediatric Pulmonology
Background:
- Bronchopulmonary dysplasia (BPD) is increasingly recognized as a chronic lung disease in infants and children.
- Major risk factors include preterm birth and respiratory distress syndrome (RDS).
Observation:
- The exact causes of BPD remain unclear, but mechanical ventilation trauma and supplemental oxygen toxicity are implicated.
- Challenges exist in BPD diagnosis, diagnostic criteria, and understanding unfavorable pulmonary mechanics.
Findings:
- The review discusses current practices in managing BPD, including home oxygen therapy programs.
- Medical management lacks prospective, controlled studies, often relying on pediatric asthma protocols.
Implications:
- Further investigation is crucial due to controversies in published long-term outcome reports for BPD patients.
- Preventing premature birth is the ultimate goal, alongside awaiting future controlled studies for improved BPD management.
Abstract:
In this review we have attempted to introduce bronchopulmonary dysplasia as a new chronic lung disease of infancy and childhood. The major risk factors for this illness are preterm birth and the respiratory distress syndrome. The precise etiology of BPD is not understood but trauma from mechanical ventilation and toxicity from exposure to supplemental oxygen are thought to be important. Problems in diagnosis and diagnostic criteria have been discussed as have the details of the unfavorable pulmonary mechanics. We have mentioned some of our own practices in regard to a large and successful home oxygen therapy program. Suggestions have been made for establishing readiness for discharge and for follow-up of these children. Medical management of these patients presently suffers from a lack of prospective and controlled studies. Medical care draws heavily from experience with pediatric asthma. What is known about the long-term outcome of these children has been reviewed with an attempt to highlight controversies between published reports and underscore the need for further investigation. The greatest future success in this area would be the prevention of premature birth. Prior to this, we must await the completion of future controlled and prospective studies.